PLoS Negl Trop Dis
October 2024
Background: Gemcitabine plus cisplatin (GC) is a highly active and commonly used regimen in locally advanced/metastatic urothelial carcinoma (la/mUC). With GC, cisplatin is dosed at 70 mg/m on day 1 of a 3-week cycle; however, for many patients, impaired renal or cardiac function, neuropathy, or poor performance status (PS) can preclude the use of cisplatin. A promising alternative is split-dose GC, in which the cisplatin dose is divided over 2 days.
View Article and Find Full Text PDFThe contribution of endocardial cells (EdCs) to the hematopoietic lineages has been strongly debated. Here, we provide evidence that in zebrafish, the endocardium gives rise to and maintains a stable population of hematopoietic cells. Using single-cell sequencing, we identify an endocardial subpopulation expressing enriched levels of hematopoietic-promoting genes.
View Article and Find Full Text PDFRecent advances in visual decoding have enabled the classification and reconstruction of perceived images from the brain. However, previous approaches have predominantly relied on stationary, costly equipment like fMRI or high-density EEG, limiting the real-world availability and applicability of such projects. Additionally, several EEG-based paradigms have utilized artifactual, rather than stimulus-related information yielding flawed classification and reconstruction results.
View Article and Find Full Text PDF